Results: 1-25 | 26-36
Results: 1-25/36
A COMPARISON OF THE SAFETY AND EFFICACY OF MIBEFRADIL AND NIFEDIPINE SR IN PATIENTS WITH RENAL-DISEASE AND HYPERTENSION
Authors: WOITTIEZ AJJ HUYSMANS FTM BAILEY R ROBSON RA MION D VILLA G KOBRIN I
Citation: Ajj. Woittiez et al., A COMPARISON OF THE SAFETY AND EFFICACY OF MIBEFRADIL AND NIFEDIPINE SR IN PATIENTS WITH RENAL-DISEASE AND HYPERTENSION, Clinical nephrology, 49(3), 1998, pp. 160-166
ADDING THE NEW CALCIUM-ANTAGONIST MIBEFRADIL TO PATIENTS RECEIVING LONG-TERM BETA-BLOCKER THERAPY RESULTS IN IMPROVED ANTIANGINAL AND ANTIISCHEMIC EFFICACY
Authors: SCHNEEWEISS A KOBRIN I CHARLON V CASPI A MARMOR A SCLAROVSKY S REISIN L SCHLESINGER Z
Citation: A. Schneeweiss et al., ADDING THE NEW CALCIUM-ANTAGONIST MIBEFRADIL TO PATIENTS RECEIVING LONG-TERM BETA-BLOCKER THERAPY RESULTS IN IMPROVED ANTIANGINAL AND ANTIISCHEMIC EFFICACY, The American heart journal, 135(2), 1998, pp. 272-280
ADDITIONAL ANTIANGINAL AND ANTIISCHEMIC EFFICACY OF MIBEFRADIL IN PATIENTS PRETREATED WITH A BETA-BLOCKER FOR CHRONIC STABLE ANGINA-PECTORIS
Authors: ALPERT JS KOBRIN I DEQUATTRO V FRIEDMAN R SHEPHERD A FENSTER PE THADANI U
Citation: Js. Alpert et al., ADDITIONAL ANTIANGINAL AND ANTIISCHEMIC EFFICACY OF MIBEFRADIL IN PATIENTS PRETREATED WITH A BETA-BLOCKER FOR CHRONIC STABLE ANGINA-PECTORIS, The American journal of cardiology, 79(8), 1997, pp. 1025-1030
ANTIANGINAL AND ANTIISCHEMIC EFFECTS OF MIBEFRADIL, A NEW T-TYPE CALCIUM-CHANNEL ANTAGONIST
Authors: KOBRIN I BIESKA G CHARLON V LINDBERG E PORDY R
Citation: I. Kobrin et al., ANTIANGINAL AND ANTIISCHEMIC EFFECTS OF MIBEFRADIL, A NEW T-TYPE CALCIUM-CHANNEL ANTAGONIST, Cardiology, 89, 1998, pp. 23-32
ANTIANGINAL AND ANTIISCHEMIC EFFECTS OF MIBEFRADIL IN THE TREATMENT OF PATIENTS WITH CHRONIC STABLE ANGINAL PECTORIS
Authors: ALPERT JS BAKX ALM BRAUN S FRISHMAN WH SCHNEEWEISS A TZIVONI D KOBRIN I
Citation: Js. Alpert et al., ANTIANGINAL AND ANTIISCHEMIC EFFECTS OF MIBEFRADIL IN THE TREATMENT OF PATIENTS WITH CHRONIC STABLE ANGINAL PECTORIS, The American journal of cardiology, 80(4B), 1997, pp. 20-26
ANTIHYPERTENSIVE EFFECTS OF MIBEFRADIL - A DOUBLE-BLIND COMPARISON WITH DILTIAZEM-CD
Authors: MASSIE BM CHRYSANT SG JAIN A WEIR M WEISS R KOBRIN I
Citation: Bm. Massie et al., ANTIHYPERTENSIVE EFFECTS OF MIBEFRADIL - A DOUBLE-BLIND COMPARISON WITH DILTIAZEM-CD, Clinical cardiology, 20(6), 1997, pp. 562-568
ANTIHYPERTENSIVE EFFECTS OF MIBEFRADIL IN THE TREATMENT OF MILD-TO-MODERATE SYSTEMIC HYPERTENSION
Authors: OPARIL S BERNINK P BURSZTYN M CARNEY S KOBRIN I
Citation: S. Oparil et al., ANTIHYPERTENSIVE EFFECTS OF MIBEFRADIL IN THE TREATMENT OF MILD-TO-MODERATE SYSTEMIC HYPERTENSION, The American journal of cardiology, 80(4B), 1997, pp. 12-19
ANTIHYPERTENSIVE PROPERTIES OF THE NOVEL CALCIUM-ANTAGONIST MIBEFRADIL (RO-40-5967) - A NEW-GENERATION OF CALCIUM-ANTAGONISTS
Authors: BERNINK PJLM PRAGER G SCHELLING A KOBRIN I
Citation: Pjlm. Bernink et al., ANTIHYPERTENSIVE PROPERTIES OF THE NOVEL CALCIUM-ANTAGONIST MIBEFRADIL (RO-40-5967) - A NEW-GENERATION OF CALCIUM-ANTAGONISTS, Hypertension, 27(3), 1996, pp. 426-432
A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING MIBEFRADIL AND AMLODIPINE - 2 LONG-ACTING CALCIUM-ANTAGONISTS WITH SIMILAR EFFICACY BUT DIFFERENT TOLERABILITY PROFILES
Authors: VISKOPER RJ BERNINK PJLM SCHELLING A RIBEIRO AB KANTOLA IM WILKINS MR KOBRIN I
Citation: Rj. Viskoper et al., A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING MIBEFRADIL AND AMLODIPINE - 2 LONG-ACTING CALCIUM-ANTAGONISTS WITH SIMILAR EFFICACY BUT DIFFERENT TOLERABILITY PROFILES, Journal of human hypertension, 11(6), 1997, pp. 387-393
DIFFERENTIAL PROPERTIES OF MIBEFRADIL IN HYPERTENSION AND ANGINA
Authors: KOBRIN I
Citation: I. Kobrin, DIFFERENTIAL PROPERTIES OF MIBEFRADIL IN HYPERTENSION AND ANGINA, Journal of hypertension, 15, 1997, pp. 33-40
DOSE-RESPONSE CHARACTERISTICS OF MIBEFRADIL, A NOVEL CALCIUM-ANTAGONIST, IN THE TREATMENT OF ESSENTIAL-HYPERTENSION
Authors: OPARIL S KOBRIN I ABERNETHY DR LEVINE BS REIF MC SHEPHERD AM
Citation: S. Oparil et al., DOSE-RESPONSE CHARACTERISTICS OF MIBEFRADIL, A NOVEL CALCIUM-ANTAGONIST, IN THE TREATMENT OF ESSENTIAL-HYPERTENSION, American journal of hypertension, 10(7), 1997, pp. 735-742
EFFECT OF MIBEFRADIL (MIB) ON DAILY ISCHEMIC EPISODES WITH AND WITHOUT INCREASE IN HEART-RATE
Authors: TZIVONI D GILULA Z KLUTSTEIN M REISIN L BOTVIN S KOBRIN I
Citation: D. Tzivoni et al., EFFECT OF MIBEFRADIL (MIB) ON DAILY ISCHEMIC EPISODES WITH AND WITHOUT INCREASE IN HEART-RATE, Journal of the American College of Cardiology, 31(2), 1998, pp. 447-447
EFFECTS OF A NEW CALCIUM-ANTAGONIST, MIBEFRADIL (RO-40-5967), ON SILENT ISCHEMIA IN PATIENTS WITH STABLE CHRONIC ANGINA-PECTORIS - A MULTICENTER PLACEBO-CONTROLLED STUDY
Authors: BRAUN S VANDERWALL EE EMANUELSSON H KOBRIN I
Citation: S. Braun et al., EFFECTS OF A NEW CALCIUM-ANTAGONIST, MIBEFRADIL (RO-40-5967), ON SILENT ISCHEMIA IN PATIENTS WITH STABLE CHRONIC ANGINA-PECTORIS - A MULTICENTER PLACEBO-CONTROLLED STUDY, Journal of the American College of Cardiology, 27(2), 1996, pp. 317-322
EFFECTS OF A NEW CALCIUM-CHANNEL BLOCKER IN PATIENTS WITH STABLE ANGINA-PECTORIS
Authors: BAKX AL VANDERWALL EE BRAUN S EMANUELSSON H KOBRIN I BRUSCHKE AV
Citation: Al. Bakx et al., EFFECTS OF A NEW CALCIUM-CHANNEL BLOCKER IN PATIENTS WITH STABLE ANGINA-PECTORIS, Journal of the American College of Cardiology, 1994, pp. 10000416-10000416
EFFECTS OF AN ORALLY ACTIVE RENIN INHIBITOR, RO 42-5892, IN PATIENTS WITH ESSENTIAL-HYPERTENSION
Authors: KOBRIN I VISKOPER RJ LASZT A BOCK J WEBER C CHARLON V
Citation: I. Kobrin et al., EFFECTS OF AN ORALLY ACTIVE RENIN INHIBITOR, RO 42-5892, IN PATIENTS WITH ESSENTIAL-HYPERTENSION, American journal of hypertension, 6(5), 1993, pp. 349-356
EFFECTS OF THE NEW CALCIUM-ANTAGONIST MIBEFRADIL (RO-40-5967) ON EXERCISE DURATION IN PATIENTS WITH CHRONIC STABLE ANGINA-PECTORIS - A MULTICENTER, PLACEBO-CONTROLLED STUDY
Authors: BAKX ALM VANDERWALL EE BRAUN S EMANUELSSON H BRUSCHKE AVG KOBRIN I
Citation: Alm. Bakx et al., EFFECTS OF THE NEW CALCIUM-ANTAGONIST MIBEFRADIL (RO-40-5967) ON EXERCISE DURATION IN PATIENTS WITH CHRONIC STABLE ANGINA-PECTORIS - A MULTICENTER, PLACEBO-CONTROLLED STUDY, The American heart journal, 130(4), 1995, pp. 748-757
EFFICACY OF MIBEFRADIL COMPARED WITH AMLODIPINE IN SUPPRESSING EXERCISE-INDUCED AND DAILY SILENT ISCHEMIA - RESULTS OF A MULTICENTER, PLACEBO-CONTROLLED TRIAL
Authors: TZIVONI D KADR H BRAAT S RUTSCH W RAMIRES JA KOBRIN I
Citation: D. Tzivoni et al., EFFICACY OF MIBEFRADIL COMPARED WITH AMLODIPINE IN SUPPRESSING EXERCISE-INDUCED AND DAILY SILENT ISCHEMIA - RESULTS OF A MULTICENTER, PLACEBO-CONTROLLED TRIAL, Circulation, 96(8), 1997, pp. 2557-2564
EVALUATING THE SAFETY OF MIBEFRADIL, A SELECTIVE T-TYPE CALCIUM-ANTAGONIST, IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE
Authors: VANDERVRING JAFM BERNINK PJLM VANDERWALL EE VANVELHUISEN DJ BRAUN S KOBRIN I
Citation: Jafm. Vandervring et al., EVALUATING THE SAFETY OF MIBEFRADIL, A SELECTIVE T-TYPE CALCIUM-ANTAGONIST, IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE, Clinical therapeutics, 18(6), 1996, pp. 1191-1206
GENDER DIFFERENCES IN RESPONSE TO TREATMENT WITH MIBEFRADIL, A SELECTIVE T-CHANNEL BLOCKER
Authors: KOBRIN I PORDY R
Citation: I. Kobrin et R. Pordy, GENDER DIFFERENCES IN RESPONSE TO TREATMENT WITH MIBEFRADIL, A SELECTIVE T-CHANNEL BLOCKER, Journal of hypertension, 16, 1998, pp. 27106-27106
HEMODYNAMIC AND CARDIAC EFFECTS OF THE SELECTIVE T-TYPE AND L-TYPE CALCIUM-CHANNEL BLOCKING-AGENT MIBEFRADIL IN PATIENTS WITH VARYING DEGREES OF LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION
Authors: ROUSSEAU MF HAYASHIDA W VANEYLL C HESS OM BENEDICT CR AHN S CHAPELLE F KOBRIN I POULEUR H
Citation: Mf. Rousseau et al., HEMODYNAMIC AND CARDIAC EFFECTS OF THE SELECTIVE T-TYPE AND L-TYPE CALCIUM-CHANNEL BLOCKING-AGENT MIBEFRADIL IN PATIENTS WITH VARYING DEGREES OF LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION, Journal of the American College of Cardiology, 28(4), 1996, pp. 972-979
LONG-TERM ANTIANGINAL AND ANTIISCHEMIC EFFECTS OF MIBEFRADIL, THE NEVER T-TYPE CALCIUM-CHANNEL BLOCKER - A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED COMPARISON WITH SUSTAINED-RELEASE DILTIAZEM
Authors: DAVIES GJ KOBRIN I CASPI A REISIN LH DEALBUQUERQUE DC ARMAGNIJAN D COELHO OR SCHNEEWEISS A
Citation: Gj. Davies et al., LONG-TERM ANTIANGINAL AND ANTIISCHEMIC EFFECTS OF MIBEFRADIL, THE NEVER T-TYPE CALCIUM-CHANNEL BLOCKER - A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED COMPARISON WITH SUSTAINED-RELEASE DILTIAZEM, The American heart journal, 134(2), 1997, pp. 220-228
MIBEFRADIL - A NEW T-CHANNEL SELECTIVE CALCIUM-ANTAGONIST
Authors: KOBRIN I CHARLON V LINDBERG E NEUMANN N PORDY R
Citation: I. Kobrin et al., MIBEFRADIL - A NEW T-CHANNEL SELECTIVE CALCIUM-ANTAGONIST, Medicamentos de actualidad, 33(8), 1997, pp. 523-542
MIBEFRADIL, A NOVEL CALCIUM-ANTAGONIST, IN ELDERLY PATIENTS WITH HYPERTENSION - FAVORABLE HEMODYNAMICS AND PHARMACOKINETICS
Authors: BURSZTYN M KADR H TILVIS R MARTINA B OIGMAN W TALBERG J KOBRIN I
Citation: M. Bursztyn et al., MIBEFRADIL, A NOVEL CALCIUM-ANTAGONIST, IN ELDERLY PATIENTS WITH HYPERTENSION - FAVORABLE HEMODYNAMICS AND PHARMACOKINETICS, The American heart journal, 134(2), 1997, pp. 238-247
MIBEFRADIL IN THE TREATMENT OF CHRONIC STABLE ANGINA-PECTORIS - COMPARATIVE-STUDIES WITH OTHER CALCIUM-ANTAGONISTS
Authors: DAVIES GJ TZIVONI D KOBRIN I
Citation: Gj. Davies et al., MIBEFRADIL IN THE TREATMENT OF CHRONIC STABLE ANGINA-PECTORIS - COMPARATIVE-STUDIES WITH OTHER CALCIUM-ANTAGONISTS, The American journal of cardiology, 80(4B), 1997, pp. 34-39
MIBEFRADIL IN THE TREATMENT OF SYSTEMIC HYPERTENSION - COMPARATIVE-STUDIES WITH OTHER CALCIUM-ANTAGONISTS
Authors: MASSIE BM LACOURCIERE Y VISKOPER R WOITTIEZ A KOBRIN I
Citation: Bm. Massie et al., MIBEFRADIL IN THE TREATMENT OF SYSTEMIC HYPERTENSION - COMPARATIVE-STUDIES WITH OTHER CALCIUM-ANTAGONISTS, The American journal of cardiology, 80(4B), 1997, pp. 27-33
Risultati: 1-25 | 26-36